GLP-1 agonists — including semaglutides like Ozempic and Wegovy and tirzepatides like Mounjaro and Zepbound — were originally intended to treat type 2 diabetes and obesity. But in recent months, studies have shown that these popular medications can have numerous other health benefits. Some have even claimed that GLP-1s could …
Read More »
As demand for GLP-1 medications continues to skyrocket for weight loss and diabetes, more Americans are skipping pharmacies and turning to unregulated sellers as a way to avoid high prices, insurance barriers and recurring shortages. The U.S. Food and Drug Administration has warned that so-called “gray market” GLP-1s (such as …
Read More »
Even one or two sodas a day could be disrupting your gut health enough to affect your mood, a new study has found. Researchers in Germany examined more than 900 adults — about half with clinical depression and half without — and found that those who drank more soft drinks …
Read More »